Comments
Commented by Nico Popp on January 13th, 2022 | 11:03 CET
Bayer, First Hydrogen, NEL: This is how innovative investing works!
Innovation pays off - especially on the stock market. That is because innovative products generate price fantasy, which can generate rich returns on the stock market within a very short period of time. In addition to classic trend themes, such as hydrogen, established companies can also score with innovations. We present three stocks and explain whether they offer opportunities or not.
Read
Commented by Nico Popp on January 13th, 2022 | 10:23 CET
JinkoSolar, Barsele Minerals, Barrick Gold: Where challenges are opportunities
The road to success is sometimes rocky and characterized by imponderables. Especially on the stock market, unclear situations can be good opportunities in the long run. Sometimes the market doesn't buy a company's long-term plans, or a fundamental situation overshadows what is actually a good investment story. We present three companies where there is currently a bit of sand in the gears and explain whether opportunities can arise.
Read
Commented by Armin Schulz on January 12th, 2022 | 13:42 CET
Bayer, XPhyto Therapeutics, MorphoSys - Which pharmaceutical companies bring returns?
Most recently, the pharmaceutical industry has been accused of being greedy and getting rich off Corona. While it is true that 2021 has been dominated by vaccine news, the industry can do much more than just produce vaccines against Corona. Handelsblatt ran a headline on January 10, "In the shadow of Corona," citing the growing number of cancers over the past several years. This year, more than 45 new drugs are expected to hit the market to help fight cancer and genetic defects, among other things. Today, we look at three companies that do not make Corona vaccines.
Read
Commented by Carsten Mainitz on January 12th, 2022 | 13:21 CET
Deutsche Lufthansa, Kleos Space, BYD - The picture is brightening up
Exploding infection figures, contact restrictions, and no prospect of improvement are some of the impressions one could get from the current news situation. In contrast, individual scientists are cautiously optimistic that the new variant could be the beginning of the end of the pandemic and the change to an endemic. In an endemic situation, people continue to become infected with the virus; however, by that time, most people's immune systems have already been exposed to the virus or are protected by vaccination, so there is no longer a burden on the health care system. A more normal life would thus be possible again, with significantly fewer restrictions.
Read
Commented by Mario Hose on January 12th, 2022 | 13:17 CET
Energy stocks after oil price rise: BP, Saturn Oil + Gas, Shell
The price of energy continues to be the focus of the public and investors in the new year. The price of WTI crude oil reached a new high for the year on Wednesday at almost USD 82.00 per barrel. Brent crude is currently trading at over USD 84.00 per barrel. Also, the price of Natural Gas of February 2022 contracts has increased today by 4.73% to 4.45 USD. The development in the commodity market also usually reflects in the balance sheets of producers.
Read
Commented by Stefan Feulner on January 12th, 2022 | 12:54 CET
Tilray, Ayurcann, Aurora Cannabis - When will the boom 2.0 come?
About five years ago, the boom of cannabis stocks started. Companies like Aurora Cannabis, Canopy Growth and Tilray were able to multiply within a few months. However, the boom was followed by a quick end on the stock market. With corrections of 90% in some cases, the exaggerations were harshly corrected. However, the cannabis market is still in a strong growth phase. The legalization in many countries and the cannabis 3.0 wave promise the companies enormous growth leaps in the next few years. Thus, the steep rise seen at the time could be repeated, at least to some extent.
Read
Commented by André Will-Laudien on January 12th, 2022 | 12:08 CET
Barrick Gold, MAS Gold, Deutsche Bank, Commerzbank - Breaking News: FED raises interest rates!
Loretta Mester, another member of the Federal Reserve, has signaled a key interest rate hike for March. The central bank president of Cleveland spoke to Bloomberg of conditions that led to reconsider the easing measures. It clearly indicates further tapering steps and a turn on the key rate. It would be the first rate hike since the pandemic began. There are enough indications that inflation is too high, as the last price increase for the US was plus 6.8%. Gold and banking stocks should benefit from this decision. We are looking for investment opportunities around inflation.
Read
Commented by André Will-Laudien on January 12th, 2022 | 11:03 CET
Valneva, Cardiol Therapeutics, Novavax: Hitting the nail on the head!
What is the correlation between the development of drugs or vaccines and the price of the company in question on the stock market? Difficult to answer because there is an almost infinite number of research areas in the field of biotechnology. Not all of them are at the center of media interest, while some topics, in contrast, experience true hype phases. COVID-19 is a viral disease that is to be overcome with all available research resources, and the attention on the capital markets is correspondingly high. Those who can demonstrate success in this area achieve high prices and valuations. But who will deliver the ultimate vaccine or a revolutionary drug to treat infected people? Lots of speculation, risks and opportunities in equal measure. We take a look at some interesting companies.
Read
Commented by Mario Hose on January 12th, 2022 | 10:53 CET
Trading stocks after EMA warning in focus: BioNTech, Johnson + Johnson, Moderna
On Wednesday, the German indices began with a positive sign. The German benchmark index DAX is currently quoted at a level of 16,004 points and thus around 0.04% slightly up. The companies in the second tier can also hold their ground and the MDAX last traded at 34,864 points (+0.26%), TexDAX at 3,644 points and thus 0.60% lower than the previous day. SDAX also loses and last traded at 15,969 points (-0.23%).
Read
Commented by Nico Popp on January 12th, 2022 | 10:36 CET
BYD, Altech Advanced Materials, Volkswagen: Who is as innovative as Tesla?
For years, e-cars lagged behind conventional drives in many areas: The ranges were significantly lower, and comfort remained inferior to classic combustion engines. In the meantime, however, things have changed. Chinese manufacturers, in particular, are scoring points with ranges of 1,000 km. Modern e-cars have also long been packed with gadgets that make the hearts of tech-savvy car enthusiasts beat faster. Does this mean that the development of e-cars is at an end? Not at all! We present three companies from the industry and analyze their innovative strength.
Read